Spasticity Clinical Trial
— IRMF-DIFFOfficial title:
Functional Magnetic Resonance and Diffusion Tensor Imaging in the Preoperative Assessment of Dystonia
NCT number | NCT02877836 |
Other study ID # | 9095 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | September 19, 2014 |
Est. completion date | June 3, 2016 |
Verified date | December 2021 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the organization of the motor circuit in a group of patients suffering from dystonia compared with a group of healthy controls. Deep Brain stimulation is a functional neurosurgery technique consisting in neuromodulation of the motor circuit that has been applied to dystonia. The efficiency of this technique depends on the relative preservation of the function and the structure of the motor network . The assessment of neuronal circuit by advanced techniques of functional neuroimaging in this study might contribute to expand our understanding of the abnormalities in motor circuit activation and the integrity of CNS structure underlying dystonia. This study might contribute therefore to the refinement of Deep brain stimulation indications and techniques in complex dystonia syndromes
Status | Terminated |
Enrollment | 36 |
Est. completion date | June 3, 2016 |
Est. primary completion date | June 3, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 84 Years |
Eligibility | Inclusion Criteria: - Age limits = 18 et < 85 years - Right-handed patients/healthy controls, according to Edinburgh Handedness Inventory - The participating subjects must be affiliated to the French public health system - Written consent to participate in this study For the patients - Patients affected by isolated or complex dystonia admitted to hospital in the Unit of Functional Neurosurgery in order to assess eligibility for deep cerebral stimulation therapy - Ability to understand the instructions to perform the experimental paradigm (the motor task) used in the design of the functional MRI For the healthy control subjects : - Absence of current neurologic pathology - Absence of personal history of neurologic pathology, including perinatal anoxic injury, meningitis, vascular, metabolic, inflammatory pathology, epilepsy, cranial trauma with loss of consciousness or with associated neurological symptoms. - Absence of orthopaedic injury in the upper limbs Exclusion Criteria: - Non Specific criteria - Contraindication for the realization of a MRI (pacemaker, valve prothesis non compatible with MRI, cochlear implant, aneuvrysmal clip, presence of an Intra-ocular metallic foreign object or coronary endoprosthesis) - Pregnancy, breastfeeding - Adults protected by the law - Non Specific criteria • Severe dyskinesia preventing the realization of motor task during functional MRI without general anesthesia |
Country | Name | City | State |
---|---|---|---|
France | CHU de Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Integrity of Motor circuit reorganization in dystonia | All the subjects participating in the study will undergo a Functional MRI study with a 'box and block' design comparing brain activity during the execution of a motor task and rest. Resting state fMRI will also be recorded. Statistical Parametric Mapping (SPM8) software will be used in order to perform spatially extended statistical processes to test the hypothesis whether there is a difference between both groups in functional imaging data. This analysis will provide a statistical map showing the clusters of brain activation where there is a significant difference between the group of dystonic patients and the group of healthy controls | 1 day | |
Primary | Integrity of corticospinal tract white matter in dystonia | Fractional anisotropy (FA) is a measure derived of Diffusion tensor imaging that quantifies the degree of directionality of the local tract structure. This parameter is considered to be a marker for white matter tract integrity.
FSL software will be used to analyse Diffusion Tensor Imaging (DTI) data Tract-based spatial statistics (TBSS) will be used to obtain a voxelwise statistical map comparing fractional anisotropy in the major tracts in the group ot dystonic patients and the group of healthy controls. Probabilistic tractography will be used to obtain tract-derived DTI parameters in the corticospinal and thalamocortical tracts that will be correlated with clinical scales (Burke-Fahn-Marsden Dystonia scale). Several DTI parameters will be analysed: mean fractional anisotropy, mean diffusivity, parallel and perpendicular diffusivity |
1 day | |
Secondary | Movement-related fMRI activation pattern in dystonic patients | To identify movement-related fMRI activation pattern in different subgroups of dystonic patients classified following clinical (hyperkinetic versus hypokinetic) and radiologic criteria (prepallidal versus postpallidal lesions) Statistical Parametric Mapping (SPM8) software will be used to test the hypothesis whether patients with different clinical phenotypes (hyperkinetic versus hypokinetic) or patients with different radiologic presentation (prepallidal versus postpallidal lesions) show significant differences in the pattern of brain activation related to the execution of a motor task.
This analysis will provide a statistical map showing the clusters of brain activation where there is a significant difference between both groups |
1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06150729 -
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
|
||
Completed |
NCT02400619 -
Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
|
Phase 1 | |
Completed |
NCT02261142 -
Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS
|
N/A | |
Completed |
NCT01945684 -
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT01444794 -
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
|
||
Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
Completed |
NCT02170779 -
Developing and Testing a Comprehensive MS Spasticity Management Program
|
Phase 2 | |
Recruiting |
NCT05674604 -
Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
|
||
Not yet recruiting |
NCT05926596 -
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
|
N/A | |
Terminated |
NCT01712087 -
Long-term Surveillance of the MedStream Programmable Infusion System
|
||
Completed |
NCT03906305 -
Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients
|
N/A | |
Completed |
NCT03302741 -
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
|
Phase 4 | |
Completed |
NCT02291159 -
Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke
|
N/A | |
Completed |
NCT01743651 -
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
|
Phase 3 | |
Completed |
NCT01523210 -
DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle
|
N/A | |
Completed |
NCT02073513 -
Kinesiotaping the Hand in Cerebral Palsy
|
N/A | |
Completed |
NCT00607542 -
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
|
Phase 1/Phase 2 | |
Completed |
NCT00702468 -
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
|
Phase 3 | |
Active, not recruiting |
NCT04815967 -
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
|
Phase 2/Phase 3 | |
Completed |
NCT01457352 -
Efficacy and Safety of SPARC0921 in Subjects With Spasticity
|
Phase 3 |